POSSIBLE EPIDEMIOLOGIC FACTORS ASSOCIATED WITH RUPTURE OF THE POSTERIOR TIBIAL TENDON

被引:169
作者
HOLMES, GB
MANN, RA
机构
[1] Jefferson Park Hospital, Assistant Professor of Orthopaedic Surgery, Thomas Jefferson University, Jefferson Medical College, Philadelphia, Pennsylvania, 1015 Walnut St., 501 Curtis Building
[2] Associate Clinical Professor of Orthopaedics, University of California, San Francisco, Oakland
来源
FOOT & ANKLE | 1992年 / 13卷 / 02期
关键词
D O I
10.1177/107110079201300204
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Rupture of the posterior tibial tendon has been postulated to occur, in part, as a result of degenerative changes to the tendon. This possibility was examined by a review of 67 patients (average age 57 years) diagnosed with rupture of the posterior tibial tendon. Forty-five of the 67 patients (60%) had one or more of the following positive medical histories: (1) hypertension, (2) obesity, (3) diabetes mellitus, (4) previous surgery or trauma about the medial aspect of the foot, or (5) steroid exposure. Thirty-five patients (52%) had either hypertension, diabetes mellitus, or obesity. A statistical correlation was demonstrated between rupture of the posterior tibial tendon and obesity (P = .005) and to a lesser extent hypertension (P = .025). These disorders have been uniformly associated with an acceleration of the degenerative processes associated with aging, commonly via an acceleration of microvascular and macrovascular diseases. An additional vascular risk is implicated by the known zone of hypovascularity of the posterior tibial tendon and risk of rupture secondary to systemic or local injections of corticosteroids. The prevalence of posterior tibial tendon rupture parallels the degenerative processes of aging, hypertension, diabetes mellitus, and obesity. Additionally, the effects of corticosteroids and local surgical procedures may further be associated with local vascular impairment and eventual rupture.
引用
收藏
页码:70 / 79
页数:10
相关论文
共 58 条
[1]  
Anzel S.H., Covey K.W., Weiner A.D., Lipscomb P.R., Disruption of muscles and tendons, An analysis of 1,014 cases. Surgery, 45, pp. 406-414, (1959)
[2]  
Balasubramanian P., Prathap K., The effect of injection of hydrocortisone into rabbit calcaneal tendons, J. Bone Joint Surg., 54, pp. 729-734, (1972)
[3]  
Beeson P.B., McDermott W., Textbook of Medicine, pp. 981-994, (1975)
[4]  
Blumenthal H.T., Goldenberg S., Berns A.W., Pathology and pathogenesis of the disseminated angiopathy of diabetes mellitus: on the nature and treatment of diabetes, International Congressional Series, no. 84, pp. 397-408, (1965)
[5]  
Bogardus C., Lillioja S., Mott D., Reaven G.R., Kashiwagi A., Foley J., Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians, J. Clin Invest., 73, pp. 800-805, (1984)
[6]  
Bonadonna R., Groop L., Kraemer N., DeFronzo R.A., Obesity and insulin resistance in man: a dose response study, Metabolism, 39, pp. 452-459, (1990)
[7]  
Overview of obesity in America, (1980)
[8]  
Butler W.J., Ostrander L.D., Carman W.J., Lamphiear D.E., Diabetes mellitus in Tecumseh, Michigan: prevalence, incidence and associated conditions, Am. J. Epidemiol., 116, pp. 971-980, (1982)
[9]  
Colville J., Callison J.R., White W.L., Role of mesotenon in blood supply, Plast. Reconstr. Surg., 43, pp. 53-60, (1969)
[10]  
Craddock D., Obesity and its management, pp. 2-3, (1970)